BIOSTAR PHARM-B (02563)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Zhou Quan | 01-Dec-16 | Sup | |||
| Meng Songdong | 11-Mar-22 | 29-Apr-26 | INED | Resignation due to the requirements of his principal employer. | |
| Zhu Pai | 09-Oct-21 | 23-May-25 | Non-Executive Director | Resignation to devote more time to other commitments. | |
| Ran Dong | 28-Dec-23 | 10-Apr-25 | INED | Mr. Ran Dong resigned to focus on his other personal commitments. His major concern was the uncertainty regarding the redemption of a US$5 million fund investment, which delayed the publication of the Company's 2024 results. | |
| Qi Jingyao | 27-Sep-24 | 26-Mar-25 | INED | Resignation to focus on her other personal commitments. | |
| Wang Lixin | 26-Jun-15 | 02-Jul-24 | INED | ||
| Zhang Shufeng | 17-Feb-16 | 16-Mar-21 | Sup | ||
| Tang Li | 11-Jul-02 | 29-Jun-18 | Co-Fdr | ||
| Zhang Cheng | 15-Aug-18 | 11-Nov-14 | ED | ||
| Zhang Shufeng | 16-Mar-21 | 11-Nov-14 | ChSup | ||
| Kong Rixiang | 27-Mar-21 | 10-Apr-14 | Sup | ||
| Guan Jin | 02-Mar-23 | 11-Apr-11 | ED | ||
| Liu Kailin | 31-Oct-24 | 11-Apr-11 | CoSec | ||
| Tang Jin | 28-Dec-23 | 11-Apr-11 | Non-Executive Director | ||
| Zhang Cheng | 15-Aug-18 | 11-Apr-11 | Dep GM | ||
| Chan Yik Pun | 31-Oct-24 | 12-Oct-09 | CoSec | ||
| Guan Jin | 02-Mar-23 | 07-Aug-09 | Dep GM | ||
| Qiu Rongguo | 11-Jul-02 | 07-Aug-09 | Co-Fdr, V-Ch | ||
| Tang Li | 11-Jul-02 | 30-Jul-09 | Ch | ||
| Qiu Rongguo | 11-Jul-02 | 22-May-07 | CEO |